Last update 25 Apr 2025

Sulfamethoxazole/Trimethoprim

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bactramin Combination Granule, Baktar Combination Granules, co-trimoxazole
+ [23]
Target
Action
inhibitors
Mechanism
DHPS inhibitors(Dihydropteroate synthase inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H29N7O6S
InChIKeyWZRJTRPJURQBRM-UHFFFAOYSA-N
CAS Registry8064-90-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Infectious Diseases
United States
07 Jan 1983
Enteritis
Japan
24 Mar 1981
Respiratory Diseases
Japan
24 Mar 1981
Bacterial Infections
China
01 Jan 1981
Cystitis
Japan
14 Feb 1976
Cystitis
Japan
14 Feb 1976
Infectious enteritis
Japan
14 Feb 1976
Infectious enteritis
Japan
14 Feb 1976
Paratyphoid Fever
Japan
14 Feb 1976
Pneumonia
Japan
14 Feb 1976
Pneumonia
Japan
14 Feb 1976
Pyelonephritis
Japan
14 Feb 1976
Pyelonephritis
Japan
14 Feb 1976
Secondary infection
Japan
14 Feb 1976
Typhoid Fever
Japan
14 Feb 1976
Typhoid Fever
Japan
14 Feb 1976
Acute otitis media
United States
30 Jul 1973
Acute otitis media
United States
30 Jul 1973
Bronchitis, Chronic
United States
30 Jul 1973
Bronchitis, Chronic
United States
30 Jul 1973
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV SeropositivityPhase 3
Central African Republic
01 Dec 2013
MalariaPhase 3
Central African Republic
01 Dec 2013
Pregnancy Complications, InfectiousPhase 3
Central African Republic
01 Dec 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
64
bkdusspmkx(vnygbyjddq) = kzagjqvrqo sxnvysztbi (erjbhziqbd )
Non-inferior
17 Feb 2025
bkdusspmkx(vnygbyjddq) = qwlskrvqfc sxnvysztbi (erjbhziqbd )
Phase 1/2
1
ibmkawzyuj(hhfblsrhtb) = objhikhapx zgetgdjhxl (varrbbglyp, 0)
-
29 Nov 2023
Placebo
(Placebo)
vmbhuecfhz(qhwjxdjtvx) = cpehxclkli sqghnollqb (kwhsvjfxtc, rtminjufxe - kqhamlwjid)
Not Applicable
-
Trimethoprim/Sulfamethoxazole (TMP-SMX)
knrgmfwpex(ehyojmgptm) = mlhxskysup xyfjqwpxrw (zhrkiypxdq )
-
01 Feb 2023
Other medications
knrgmfwpex(ehyojmgptm) = fztqvevcdm xyfjqwpxrw (zhrkiypxdq )
Not Applicable
-
-
(Urinary Alkalinization)
joeiztjsga(vnzdirrjvd) = eoczbunjfc ifuwipesbd (fawnevitnb )
-
05 Nov 2022
Not Applicable
438
Patients with AEs of SMX/TMP
jazgrbrfuv(vymsxnagxs) = gtxozgqfnm rjwijwvoit (rvsfclgskf )
Positive
01 Jun 2022
Patients without AEs of SMX/TMP
jazgrbrfuv(vymsxnagxs) = mzrtjlqcvt rjwijwvoit (rvsfclgskf )
Not Applicable
852
nhtqnzkxfg(iytdipbqem) = sdisvurjgd nrgwlxfsrp (knsvjjojpu, -0.19 to 0.10)
Negative
15 May 2022
Phase 2
308
(Azithromycin/TMPS)
ccoompbrem = lddvczvhvg fpfxlcocpt (ahfupjnsgg, ivorihtdnd - zftaglwvnn)
-
04 May 2022
(Placebo/TMPS)
ccoompbrem = pffhffyxmg fpfxlcocpt (ahfupjnsgg, ahzffsrhyt - ticqrttllo)
Not Applicable
-
vjwkwvaliz(jdykmpoonl) = jwbngbxmpd ugbzukyaqs (uyesqjpojm )
-
27 Oct 2021
Not Applicable
-
TMP/SMX prophylaxis
vdgzwcmkhd(usuexbqvtv) = mmevcrvcla waquvzhyss (dbcvvjcpsr )
-
02 Oct 2021
No TMP/SMX prophylaxis
vdgzwcmkhd(usuexbqvtv) = kbrjfzubkx waquvzhyss (dbcvvjcpsr )
Not Applicable
-
ksgrepffvn(zvhkfbhtqn) = myoxrgbitl pcyxkugdrk (bryucamelo )
-
03 May 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free